Vance Vanier will take over the president and CEO positions at Navigenics. Vanier started at Navigenics in 2008 and was serving as chief medical officer of the consumer genomics firm.
Before joining Navigenics, Vanier was a partner at Mohr Davidow Ventures. He also is a clinical faculty member at Stanford University Medical Center.
Klaus Lindpaintner has been hired by Strategic Diagnostics as VP of research and development and chief scientific officer.
Lindpaintner, who was director of Roche Molecular Medicine Laboratories and was global head of its policy and external affairs, will begin in his new position in February.